Switzerland-based Addex Therapeutics (SIX/Nasdaq: ADXN), a biopharma developing a portfolio of novel small molecule ...

China’s Chime Biologics has formed a strategic partnership with European biosimilars specialist Polpharma Biologics to ...

US biotech Myeloid Therapeutics has restructured its operations to concentrate on two cancer programs already in the clinic, ...

US biotech Wayfinder Biosciences has entered a research collaboration with Japanese drugmaker Daiichi Sankyo (TSE: 4568) to ...

Californian biotech Glycomine has raised $115 million in a Series C financing to advance its lead candidate, GLM101, into a ...

French drugmaker Ipsen (Euronext: IPN) today presented sales for the first quarter of 2025. The company did not release any ...

US President Donald Trump has passed an executive order that answers the pharmaceutical industry’s calls for the scrapping of ...

UK pharm major GSK (LSE: GSK) has breached the ABPI Code of Practice for the Industry and brought discredit upon, and ...

Italian pharma major Recordati (RECI: MI) today announced that the US Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) for Isturisa (osilodrostat) for the ...

US mRNA specialist Moderna (Nasdaq: MRNA) has announced that its manufacturing facility in the UK has been granted a manufacturer’s license by the Medicines and Healthcare products Regulatory Agency ...

US biotech Mural Oncology has halted all development of its lead candidate, nemvaleukin alfa, after the engineered cytokine ...

The European Commission (EC) has at last granted the amyloid-beta (Aβ) monoclonal antibody Leqembi (lecanemab) Marketing ...